Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.52 |
| ▸ | CTSA | P10619 | 1/20 | 0.47 |
| ▸ | AMY1A | P0DUB6 | 3/20 | 0.47 |
| ▸ | AKR1C3 | P42330 | 3/20 | 0.44 |
| ▸ | AKR1C2 | P52895 | 3/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.44 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.44 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.42 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.42 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.42 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16290745 | 0.85 | FFAR1 (0.44) | ERN1CYP2C19APPCYP17A1CYP11B1 | |
| SCHEMBL13865595 | 0.85 | ERN1 (0.52) | ERN1CTSAAMY1AAKR1C3AKR1C2 | |
| SCHEMBL15588476 | 0.85 | APP (0.51) | ERN1AMY1ACYP2C19APPCYP1A1 | |
| SCHEMBL30979884 | 0.85 | APP (0.51) | ERN1AMY1ACYP2C19APPCYP1A1 | |
| SCHEMBL27781767 | 0.84 | CYP2C19 (0.58) | ERN1AMY1AAKR1C3AKR1C2CYP2C19 | |
| SCHEMBL1816063 | 0.84 | CYP1A1 (0.54) | ERN1CTSAAMY1AAKR1C3AKR1C2 | |
| SCHEMBL10340365 | 0.83 | AMY1A (0.50) | ERN1AMY1ACYP2C19APPCD274 | |
| SCHEMBL12814350 | 0.83 | CD274 (0.52) | ERN1CTSAAMY1AAKR1C3AKR1C2 | |
| SCHEMBL1816823 | 0.81 | ERN1 (0.50) | ERN1AMY1AAKR1C3AKR1C2CYP2C19 | |
| SCHEMBL27494752 | 0.81 | CYP2C19 (0.51) | ERN1AKR1C3AKR1C2CYP2C19APP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8337718-B2 | Liquid crystal compound, liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2012-12-25 | — | — | US | disclosed |
| US-20110180756-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110180756-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | LASP1, VCL, NLK | ERN1 2179/4885CTSA 4033/4885AMY1A 3433/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.